Change in Designation of Whole-time Director
Caplin Point Laboratories Ltd has informed BSE that Mr. D. P. Mishra, Whole-time Director of the Company resigned from the position of the Whole-time Director from the Close of business hours on April 30, 2016 (Since, his term of Whole-time Director expires on that date) and he continues to be a Director of the Company. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Caplin Point Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended March 31, 2016
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Authorised KMPs to determine materiality of events/information
Caplin Point Laboratories Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information". Change in Chief Financial Officer
Caplin Point Laboratories Ltd has informed BSE that Mr. Harihara Ponnambalam P, Chief Financial Officer of the Company has resigned with effect from February 18, 2016 as he is pursuing some overseas assignments.Further the Company has informed that, Mr. D. Muralidharan has been appointed as Chief Financial Officer of the Company w.e.f. February 19, 2016. Grant of Employee Stock Options under Caplin Point Employee Stock Option Plan - 2015
Caplin Point Laboratories Ltd has informed BSE that the Nomination and Remuneration Committee of the Board of Directors of the Company has granted 16,050 stock options under the Caplin Point Employee Stock Option Plan - 2015 at an exercise price of Rs. 10 each, convertible into equivalent number of equity shares of the Company having face value of Rs. 10 each.These options will vest in 3 equal tranches over a period of 3 years. Financial Results & Limited Review Report for Dec 31, 2015
Caplin Point Laboratories Ltd has informed BSE about :1. Financial Results for the period ended December 31, 2015 (Standalone and Consolidated).2. Limited Review Report for the period ended December 31, 2015 (Standalone and Consolidated). Board declares Interim Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 05, 2016, inter alia, have:1. Declared an Interim Dividend of Rs. 2.50 per share (25%) for the financial year 2015-16 on the paid-up capital of Rs. 15.11 Crores represented by 1,51,10,000 equity shares of Rs. 10/- each.... Shareholding for the Period Ended December 31, 2015
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Fixes Record Date for Interim Dividend
Caplin Point Laboratories Ltd has informed BSE that the Company has fixed February 16, 2016, as the RECORD DATE for the purpose of ascertaining the eligibility of the Shareholders for the payment of Interim dividend, if any, declared by the Board.